The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)

Objective To explore the risk factors for uric acid-lowering therapy-resistant gout (UALT-RG) and its relationships with the estimated glomerular filtration rate (eGFR), body roundness index (BRI), and visceral adiposity index (VAI) via 2007–2018 National Health and Nutrition Examination Survey (NHA...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengyuan Zhu, Xingqiang Wang, Zining Peng, Weitian Yan, Qian Deng, Meihui Li, Nian Liu, Ling Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2441398
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087221380841472
author Mengyuan Zhu
Xingqiang Wang
Zining Peng
Weitian Yan
Qian Deng
Meihui Li
Nian Liu
Ling Zhang
author_facet Mengyuan Zhu
Xingqiang Wang
Zining Peng
Weitian Yan
Qian Deng
Meihui Li
Nian Liu
Ling Zhang
author_sort Mengyuan Zhu
collection DOAJ
description Objective To explore the risk factors for uric acid-lowering therapy-resistant gout (UALT-RG) and its relationships with the estimated glomerular filtration rate (eGFR), body roundness index (BRI), and visceral adiposity index (VAI) via 2007–2018 National Health and Nutrition Examination Survey (NHANES) data.Methods We calculated the BRI using waist circumference and standing height; the VAI using triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), and body mass index (BMI); and the eGFR from serum creatinine levels. We also collected gout data. We explored the relationships of the eGFR, BRI, and VAI with UALT-RG risk via univariable and multivariable weighted logistic regression, trend analysis, and restricted cubic splines.Results Among the 1,811 patients with gout, ∼9.08% had UALT-RG; these patients were more likely to have obesity, comorbid diabetes (36% [27–47%] vs. 25% [22–28%]) or impaired kidney function (eGFR < 60 mL/min/1.73 m2, 34.5% [27–43%] vs. 22.5% [20–26%]); be former smokers; and take colchicine (10% [5.6–19%] vs. 4.3% [2.8–6.7%]). Logistic regression and trend analysis suggested that an elevated BRI and decreased eGFR were independent risk factors and potential screening indicators for UALT-RG. Restricted cubic spline analysis revealed a negative linear trend between the eGFR and UALT-RG risk (p-overall < 0.0001) and a significant positive correlation between the BRI and UALT-RG risk (p-overall < 0.0001).Conclusion An increased BRI and decreased eGFR may be independent risk factors and assessment indicators for UALT-RG in U.S. adults. It is necessary to monitor serum urate levels more closely and conduct early multidisciplinary comanagement when gout is comorbid with visceral obesity and chronic kidney disease stages 3–5.
format Article
id doaj-art-57dd3fbd07f649f093471af512f44708
institution Kabale University
issn 0886-022X
1525-6049
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-57dd3fbd07f649f093471af512f447082025-02-06T06:41:45ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2024.2441398The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)Mengyuan Zhu0Xingqiang Wang1Zining Peng2Weitian Yan3Qian Deng4Meihui Li5Nian Liu6Ling Zhang7The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, P. R. ChinaDepartment of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, P. R. ChinaThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, P. R. ChinaThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, P. R. ChinaThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, P. R. ChinaThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, P. R. ChinaThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, P. R. ChinaThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, P. R. ChinaObjective To explore the risk factors for uric acid-lowering therapy-resistant gout (UALT-RG) and its relationships with the estimated glomerular filtration rate (eGFR), body roundness index (BRI), and visceral adiposity index (VAI) via 2007–2018 National Health and Nutrition Examination Survey (NHANES) data.Methods We calculated the BRI using waist circumference and standing height; the VAI using triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), and body mass index (BMI); and the eGFR from serum creatinine levels. We also collected gout data. We explored the relationships of the eGFR, BRI, and VAI with UALT-RG risk via univariable and multivariable weighted logistic regression, trend analysis, and restricted cubic splines.Results Among the 1,811 patients with gout, ∼9.08% had UALT-RG; these patients were more likely to have obesity, comorbid diabetes (36% [27–47%] vs. 25% [22–28%]) or impaired kidney function (eGFR < 60 mL/min/1.73 m2, 34.5% [27–43%] vs. 22.5% [20–26%]); be former smokers; and take colchicine (10% [5.6–19%] vs. 4.3% [2.8–6.7%]). Logistic regression and trend analysis suggested that an elevated BRI and decreased eGFR were independent risk factors and potential screening indicators for UALT-RG. Restricted cubic spline analysis revealed a negative linear trend between the eGFR and UALT-RG risk (p-overall < 0.0001) and a significant positive correlation between the BRI and UALT-RG risk (p-overall < 0.0001).Conclusion An increased BRI and decreased eGFR may be independent risk factors and assessment indicators for UALT-RG in U.S. adults. It is necessary to monitor serum urate levels more closely and conduct early multidisciplinary comanagement when gout is comorbid with visceral obesity and chronic kidney disease stages 3–5.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2441398Glomerular filtration ratebody roundness indexrefractory gouthyperuricemiaobesityNHANES
spellingShingle Mengyuan Zhu
Xingqiang Wang
Zining Peng
Weitian Yan
Qian Deng
Meihui Li
Nian Liu
Ling Zhang
The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)
Renal Failure
Glomerular filtration rate
body roundness index
refractory gout
hyperuricemia
obesity
NHANES
title The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)
title_full The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)
title_fullStr The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)
title_full_unstemmed The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)
title_short The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007–2018)
title_sort role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid lowering therapy resistant gout in u s adults evidence from the national health and nutrition examination survey 2007 2018
topic Glomerular filtration rate
body roundness index
refractory gout
hyperuricemia
obesity
NHANES
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2441398
work_keys_str_mv AT mengyuanzhu theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT xingqiangwang theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT ziningpeng theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT weitianyan theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT qiandeng theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT meihuili theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT nianliu theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT lingzhang theroleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT mengyuanzhu roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT xingqiangwang roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT ziningpeng roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT weitianyan roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT qiandeng roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT meihuili roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT nianliu roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018
AT lingzhang roleoftheestimatedglomerularfiltrationrateandbodyroundnessindexintheriskassessmentofuricacidloweringtherapyresistantgoutinusadultsevidencefromthenationalhealthandnutritionexaminationsurvey20072018